An Integrated Multiplexing Approach Identifies IDO1 as a Biomarker for Recurrence of Rare Ovarian Granulosa Cell Tumors
Presented at The Society for Immunotherapy of Cancer (SITC)
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients